Why Is OSCR Stock Rising Today?

The company expects fiscal 2026 revenue to be between $18.7 billion and $19 billion, compared with $11.70 billion in fiscal 2025.

📰 Article Image

In this photo illustration, the logo of Oscar Health, Inc. is displayed on a smartphone screen on May 04, 2025, in Chongqing, China. (Photo illustration by Cheng Xin/Getty Images)

👤

Arnab Paul · Stocktwits

Published Feb 10, 2026, 11:31 AM

OSCR
  • Oscar Health’s Q4 total revenue came in at $2.81 billion, below estimates of $3.12 billion, according to Fiscal.ai data.
  • The company’s medical loss ratio was 95.1% compared to 88.1% last year.
  • Oscar Health expects to return to profitability in 2026, eyeing earnings from operations in the range of $250 million to $450 million.

Oscar Health (OSCR) shares traded nearly 5% higher on Tuesday morning after the company projected fiscal 2026 revenue well above the FY2025 level reported alongside its fourth-quarter results.

Q4 Snapshot

The company forecast fiscal 2026 revenue between $18.7 billion and $19 billion, compared with $11.70 billion in fiscal 2025. However, the health insurer’s fourth-quarter (Q4) total revenue came in at $2.81 billion, significantly below the Street estimates of $3.12 billion, according to Fiscal.ai data. Oscar also reported a loss of $1.24 per share, wider than the estimates of a loss of $0.92 per share.

The company’s medical loss ratio (MLR) was 95.1%, meaning 95.1% of total premiums paid by policyholders went toward claims, with the remaining 4.9% retained by the insurer. It was 88.1% last year.

As of Feb. 1, 2026, Oscar served about 3.4 million members.

Firm Eyes Profitability In 2026

CFO Scott Blackley said in a call with analysts that the firm expects to meaningfully improve financial performance and return to profitability in 2026.

“We expect earnings from operations to be in the range of $250 million to $450 million, a significant improvement of nearly $750 million year-over-year, implying an operating margin of approximately 1.9% at the midpoint. Adjusted EBITDA is expected to be approximately $115 million higher than earnings from operations,” Blackley said.

Oscar Health posted a net loss in five of the last six quarters, according to Koyfin data.

On February 6, the company secured a $475 million, three-year revolving credit facility, which Blackley said will provide flexibility to support long-term growth and expand adoption in the individual market.

How Did Stocktwits Users React?

Retail sentiment on Stocktwits flipped to ‘extremely bullish’ from ‘bearish’ a day back, amid ‘extremely high’ message volumes. OSCR was among the top trending tickers at the time of writing.

📷

One user was bullish about the guidance, expecting the stock price to double over the coming weeks.

Another user highlighted that they are adding to their position.

Year-to-date, the stock has declined around 10%

Read also: SIDU Stock Gained 5% In Pre-Market Today – What Is The Deal With Simera Sense About?

For updates and corrections, email newsroom[at]stocktwits[dot]com